Drug delivery and translational research
Formulation and characterization of exenatide-loaded PLGA microspheres prepared by coacervation.
Cameron White, Steven P Schwendeman
Published: 202510.1007/s13346-025-02008-2
Abstract
Bydureon® is a once-weekly injection of poly(lactide-co-glycolide) (PLGA) microspheres containing exenatide acetate, a synthetic analog of the GLP-1 receptor agonist exendin-4. These microspheres are formulated by coacervation (i.e., phase separation…
Preview only. Read the full abstract at the source